Skip to main content
. 2022 May 23;298(7):102063. doi: 10.1016/j.jbc.2022.102063

Table 1.

In vitro antiproliferative activities of the target compounds 6a–6x

Compound IC50 (μM)
A549 SGC-7901 MCF-7
6a 9.34 3.16 0.219
6b 0.292 0.285 1.06
6c 1.45 1.06 0.542
6d 0.850 >10 0.106
6e 1.04 0.272 0.244
6f 17.7 >30 0.219
6g 0.985 0.126 0.257
6h 0.063 0.120 0.094
6i 0.211 0.117 0.130
6j 2.42 0.535 1.74
6k 4.26 1.68 1.99
6l 0.755 0.098 0.497
6m 0.150 0.120 0.116
6n 2.05 2.48 1.41
6o 1.43 2.78 0.999
6p 5.99 7.69 4.90
6q 0.848 0.570 0.324
6r 1.15 1.08 0.194
6s >30 0.595 4.21
6t 0.825 1.07 0.203
6u >30 2.93 3.10
6v 0.496 3.25 4.94
6w 0.932 0.964 2.01
6x 5.06 0.394 4.68
Colchicinea 0.107 0.043 0.059
SMARTa 0.089 0.019 0.048
a

Used as positive controls.